Skip to main navigation Skip to main content
  • KSCN
  • E-Submission

CNR : Clinical Nutrition Research

OPEN ACCESS
ABOUT
BROWSE ARTICLES
EDITORIAL POLICIES
FOR CONTRIBUTORS

Page Path

3
results for

"Parivash Shekarchizadeh-Esfahani"

Article category

Keywords

Publication year

Authors

"Parivash Shekarchizadeh-Esfahani"

Review Articles
[English]
Effects of Fish Oil Supplementation on Serum C-Reactive Protein Levels in Trained Individuals: A Systematic Review of Clinical Trials
Parivash Shekarchizadeh-Esfahani, Leili Khaghani, Jahangir Karimian
Clin Nutr Res 2025;14(2):139-145.   Published online April 28, 2025
DOI: https://doi.org/10.7762/cnr.2025.14.2.139

Exercise, especially when prolonged or highly intense, can temporarily increase inflammation in both trained and untrained individuals. C-reactive protein (CRP) is an established biomarker of inflammation. However, clinical trials assessing the impact of fish oil supplementation on CRP levels in trained individuals have yielded inconsistent and often contradictory results. The main
objective
of this study was to conduct a systematic review of clinical trials exploring the effects of fish oil supplementation on CRP levels among trained individuals. We performed structured searches on the PubMed, Scopus, and ISI Web of Science databases for articles published from the earliest available date until September 2023. Of the 385 articles found and screened, three clinical trials met our criteria for inclusion in this review. The results suggested that fish oil supplementation may help prevent spikes in CRP levels after exercise. However, only one of the three studies produced statistically significant findings. The differences in statistical significance among these studies could be due to variations in the study design, sample populations, dosages, and duration of supplementation. In summary, this systematic review provides evidence that fish oil supplementation can reduce circulating CRP levels in trained individuals. Additional studies with long-term follow-up and larger sample sizes are needed to investigate this effect further.

  • 16 View
  • 0 Download
[English]
Flaxseed Lowers Blood Pressure in Hypertensive Subjects: A Meta-Analysis of Randomized Controlled Trials
Ezatollah Fazeli Moghadam, Leili Khaghani, Parivash Shekarchizadeh-Esfahani
Clin Nutr Res 2024;13(4):295-306.   Published online October 29, 2024
DOI: https://doi.org/10.7762/cnr.2024.13.4.295

This systematic review and meta-analysis study aimed to evaluate the effectiveness of flaxseed supplementation on blood pressure (BP) in patients with hypertension based on the data from randomized clinical trials (RCTs). Three databases (PubMed [MEDLINE], Scopus, and ISI Web of Science) were searched from inception up to August 10, 2024. Relevant studies meeting our eligibility criteria were obtained. A random-effects model was used to estimate pooled weighted mean differences (WMDs) with 95% confidence intervals (CIs). The methodological quality of individual studies was assessed using the Cochrane Collaboration risk of bias tool. A total of 5 studies were included and analyzed using STATA software version 12. The results show that there is a significant decrease in systolic BP (WMD, −8.64 mmHg; 95% CI, −15.41 to −1.87; p ≤ 0.001) and diastolic BP (WMD, −4.87 mmHg; 95% CI, −8.37 to −1.37; p = 0.006) of patients with hypertension as compared to control groups. This study supported that flaxseed supplementation had favorable effects on BP control in hypertensive patients. It may be a promising adjuvant therapy for patients with hypertension.

Citations

Citations to this article as recorded by  
  • Albumin-Bound Fatty Acids Modulate Endogenous Angiotensin-Converting Enzyme (ACE) Inhibition
    Enikő Edit Enyedi, Attila Ádám Szabó, Tamás Bence Pintér, Ivetta Siket Mányiné, Anna Pluhár, Csongor Váradi, Emese Bányai, Attila Tóth, Zoltán Papp, Miklós Fagyas
    Biomedicines.2026; 14(1): 103.     CrossRef
  • Dietary flaxseed: Cardiometabolic benefits and its role in promoting healthy aging
    Setor K. Kunutsor, Davinder S. Jassal, Amir Ravandi, Andrea Lehoczki
    GeroScience.2025; 47(3): 2895.     CrossRef
  • 165 View
  • 0 Download
  • 2 Crossref
[English]
Soy Supplementation Does Not Affect Serum Adiponectin Levels in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Jahangir Karimian, Parivash Shekarchizadeh-Esfahani
Clin Nutr Res 2024;13(2):130-138.   Published online May 2, 2024
DOI: https://doi.org/10.7762/cnr.2024.13.2.130

Numerous studies have indicated that low levels of serum adiponectin are linked with the development of various chronic diseases. While some recent research has suggested that soy has a positive impact on serum adiponectin levels, the results are inconsistent. Therefore, we aim to conduct a thorough systematic review and meta-analysis of randomized controlled trials (RCTs) that investigate the effects of soy on serum adiponectin levels in adults. The search was conducted until March 2024 on PubMed, Scopus, Web of Science, and Cochrane Library databases to identify RCTs that studied the effects of soy supplementation on serum adiponectin levels. A random-effects model was used to pool the weighted mean differences (WMDs). Ten and nine RCTs were selected for the systematic review and meta-analysis, respectively. After analyzing data from 9 eligible RCTs, it was found that soy supplementation did not significantly impact the concentrations of adiponectin (WMD = −0.24 μg/mL; 95% confidence interval, −1.56 to 1.09; p = 0.72). However, there was significant heterogeneity between the studies (I2 = 89.8%, p < 0.001). Sensitivity analysis showed that overall estimates were not affected by the elimination of any study. We did not observe any evidence regarding publication bias. In conclusion, soy supplementation did not have a significant effect on adiponectin levels in adults. However, further RCTs are needed with longer intervention duration, higher doses, and studies conducted in different countries.

Citations

Citations to this article as recorded by  
  • The correlation between proprotein convertase subtilisin/kexin type 9 and adiponectin in the progression from prediabetes to type 2 diabetes mellitus
    Jun-Xu Gu, Kun Wang, Ai-Min Zhang, Yue Yin, Shan-Shan Li, Na Zhang, Li Qin, Chun-Yan Wang, Lin Pei, Mei Jia, Ming Su
    Scientific Reports.2025;[Epub]     CrossRef
  • 9 View
  • 0 Download
  • 1 Crossref